3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
22
Neoplasms
20
Lung Neoplasms
10
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
6
Papillomavirus Infections
5
Head and Neck Neoplasms
5
Fatigue
5
Multiple Myeloma
4
Lymphoma
4
Hematologic Neoplasms
4
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Prostatic Neoplasms
3
Melanoma
3
Hematopoietic and Lymphoid System Neoplasm
3
Gastrointestinal Neoplasms
3
Sleep Wake Disorders
2
Skin Cancer Prevention
2
Obesity
2
Neoplasm Metastasis
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematopoietic and Lymphatic System Neoplasm
2
Diabetes Mellitus
2
Depression
2
Caregiver
2
Cancer Survivor
2
Interventions
padeliporfin
4
Nivolumab
4
Gemcitabine
4
Cyclophosphamide
4
130-nm albumin-bound paclitaxel
4
napabucasin
3
Pemetrexed
3
Fluorouracil
3
Albumin-Bound Paclitaxel
3
ficlatuzumab
2
Trastuzumab
2
Trabectedin
2
Paclitaxel
2
Leucovorin
2
Irinotecan
2
Bevacizumab
2
sotorasib
1
selinexor
1
ribociclib
1
relatlimab
1
pralsetinib
1
pembrolizumab
1
pamiparib
1
osimertinib
1
nintedanib
1
ipatasertib
1
guadecitabine
1
glutathione pegylated liposomal doxorubicin
1
exemestane
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms by Site
×
Educational Status
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts